Amid Concerns Over Medicine Safety In India, Majority Wants Mandatory Side Effects Disclosure: Survey
The survey underscores the significance of medicine safety concerns in India, with over half of respondents or their family members having faced unknown side effects in the past five years.
Sep 07, 2023, 09:48 AM IST
Bharat Biotech seeks approval for Covaxin booster trials for 2-18 age group
Hyderabad-based vaccine manufacturer Bharat Biotech has sought permission to conduct booster dose trials of its Covid vaccine Covaxin for below 18 population.
May 05, 2022, 19:37 PM IST
Centre forms panel to frame new law to regulate drugs, cosmetics, medical devices
The eight-member panel is expected to submit a draft document by November 30 that will help formulate the new Drugs, Cosmetics and Medical Devices Bill which could be taken up in the parliament to be enacted.
Sep 08, 2021, 16:03 PM IST
COVID-19: Serum Institute gets DCGI nod to manufacture Sputnik V vaccine in India
SII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its licensed Hadapsar facility.
Jun 04, 2021, 20:36 PM IST
DNA Exclusive: Covisheild vaccine finally gets emergency use approval; check all details
The indigenous COVID-19 vaccine, Covisheild, has already been recommended for emergency use and it will reach people in a few days, but its side effects have scared people.
Jan 02, 2021, 01:23 AM IST
Eight Chinese pharma firms may be blacklisted over quality issues
The Indian government has issued showcause notices to eight Chinese pharmaceutical companies found to be supplying poor quality raw material to drug manufacturers.
Jan 07, 2018, 14:53 PM IST
1,200 new list of drugs to be banned in India by regulator
Zee Media Bureau
Mar 18, 2016, 10:17 AM IST
Mankind Pharma launches diabetes drug 'Dynaglipt'
Mankind Pharma has launched an anti-diabetic product 'Dynaglipt' targeting the middle class and rural diabetic patients.
Nov 23, 2015, 17:22 PM IST
Delhi HC allows DCGI to process Reliance's package insert of cancer drug
Delhi High Court today told the Drug Controller General of India (DCGI) that it can process the application of Reliance Life Sciences for approving the package insert of its breast cancer drug, the launch of which has been put on hold by a single judge of the court.
Nov 19, 2015, 20:46 PM IST
Govt initiates steps to promote clinical research in India
The government has initiated a series of steps to fast-track approvals for clinical trials in India.
Nov 13, 2015, 12:11 PM IST
Government may bar pharma firms from giving gifts to doctors
Pharma companies may soon be barred from giving any gift, cash or offer hospitality to doctors, as government is considering making it mandatory for them to follow uniform marketing practices code.
Oct 11, 2015, 15:30 PM IST
